Tag: medical therapeutics
Proteios Technology Awarded $1.6M NIH SBIR Grant to Commercialize its Multivariate Cell Isolation Technology
eNewsChannels NEWS: -- Proteios Technology, Inc. is pleased to announce it's received a $1.6 million SBIR Phase II grant from the National Institutes of Health (NIH) to commercialize its multivariate (parallel) cell isolation technology. Grant funds will be used to extend Proteios' cell isolation kits to include up to 20 of the most common cell types currently used in cell therapy development.
ProNova Partners offers End-to-end transport Solution for Medical therapies and Products Relying on Cold Chain: Secure, Traceable, Reusable
eNewsChannels NEWS: -- Southern California based Mergers and Acquisitions firm ProNova Partners has been commissioned to facilitate investment in or the sale of a patented, groundbreaking packaging technology. The technology facilitates a secure, traceable, and reusable end-to-end transport solution for expensive medical therapies and products that rely on the cold chain.
